A prospective, single-center, phase II clinical study of fruquintinib combined with sintilimab and electroacupuncture for the treatment of microsatellite stable advanced metastatic colorectal cancer after second-line and second-line treatment

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 6dc98a98633bc03fe0982bf86bd706acf3a082b7
First added on: Apr 08, 2025